We investigated the effects of PD-1 and CD28 on anti-tumor responses of lymphocytes in two breast cancer cell lines in vitro.<h4>Results</h4>Patients with high CD28 and low PD-1 on T cells were more sensitive to chemotherapy. This evidence concerns the gene CD28 and neoplasm.